ALLIENT INC ALNT revenue by segment, product and geography
In its fiscal year ending 2025-12-31, ALLIENT INC reported revenue across 5 products and services; the largest, Industrial And Electronics, was $268M, 48.4% of the filed sum (+8.1% against the prior period in the same filing).
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- Industrial And Electronics$268M48.4%+8.1% yoy
- Vehicle$97M17.5%-5.5% yoy
- Medical$81.7M14.7%+4.8% yoy
- Aerospace And Defense$81.3M14.7%+8.2% yoy
- Distribution And Other Target Market$26M4.7%+0.8% yoy
Members sum to the consolidated $554M for this period.
- United States$369Mshare n/a+2.7% yoy
- Outside United States$248Mshare n/a+3.2% yoy
- Europe$161Mshare n/a+10.3% yoy
- Asia$24.9Mshare n/a-1.5% yoy
member sum exceeds the consolidated figure: this axis carries more than one breakdown, so shares are not computed.
- Industrial And Electronics$67.2M48.4%+7.7% yoy
- Vehicle$24.6M17.7%+7.2% yoy
- Aerospace And Defense$20.5M14.7%-2.7% yoy
- Medical$19.5M14.0%+1.9% yoy
- Distribution And Other Target Market$7.09M5.1%-2.4% yoy
Change is against the same quarter a year earlier, as reported in the same 10-Q.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
About these figures
Companies tag segment, product and geographic revenue as dimensional XBRL facts in their 10-K and 10-Q filings. The SEC publishes those facts in its DERA Financial Statement and Notes data sets; TrendNalysis ingests each monthly file and serves the facts exactly as filed, keyed to the accession of the filing. Shares are of the filed sum. Where a filer tags more than one breakdown on one axis, the sum exceeds consolidated revenue and no shares are computed; where the members do not add up to the consolidated figure, the residual is stated rather than hidden. Missing is never zero.
Descriptive and educational; not investment advice. Methodology and data lineage.